Academic biography

Dr. Jianghui Meng is a PI in Molecular Neuroscience and Neurotherapeutics in the National Institute of Cellular Biotechnology, is funded by SFI, Sanofi, and LEO foundation on the translational neuroscience and dermatology.  Dr. Meng’s current research interests are focused on defining the itch and pain signaling pathways, elucidating neuroimmune modulation of chronic itch and pain, and developing novel analgesics and antipruritics. These therapeutics have advantages being effective and cost-efficient, with abilities to change patients’ life in a meaningful way. Dr. Meng has established several novel concepts for itch and pain management and identified novel therapeutic interventions, which formed the new basis for the accomplishment of transformational “mechanism-based” high-quality treatments.